利妥昔單抗治療富亮氨酸膠質瘤失活 1 蛋白抗體腦炎一例_West China Medical Journal

Authors：

李靜雅 , 張婧 ,  王琳

Corresponding?author：

王琳, Email: wanglinyiwan@126.com

Keywords：

富亮氨酸膠質瘤失活 1 蛋白抗體腦炎; 利妥昔單抗; 面臂肌張力障礙

DOI：

10.7507/1002-0179.202104271

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李靜雅, 張婧, 王琳. 利妥昔單抗治療富亮氨酸膠質瘤失活 1 蛋白抗體腦炎一例. West China Medical Journal, 2021, 36(6): 833-834. doi: 10.7507/1002-0179.202104271 Copy

1.	中華醫學會神經病學分會. 中國自身免疫性腦炎診治專家共識. 中華神經科雜志, 2017, 50(2): 91-98.
2.	van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology, 2016, 87(14): 1449-1456.
3.	張婧, 趙文博, 武力勇. 富亮氨酸膠質瘤失活 1 蛋白 A 自身抗體相關邊緣性腦炎 6 例臨床分析. 中華實用診斷與治療雜志, 2015, 29(10): 995-996.
4.	Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol, 2013, 265(1/2): 75-81.
5.	Markovic I, Basic S, Devedjija S. Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab-a case report. Neurol Sci, 2020, 41(7): 1949-1950.
6.	Brown JW, Martin PJ, Thorpe JW, et al. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. J Neuroimmunol, 2014, 271(1/2): 66-68.
7.	Bhandari B, Basyal B, Sendil S, et al. Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis. J Community Hosp Intern Med Perspect, 2020, 10(4): 377-379.
8.	Nosadini M, Mohammad SS, Ramanathan S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother, 2015, 15(12): 1391-1419.

1. 中華醫學會神經病學分會. 中國自身免疫性腦炎診治專家共識. 中華神經科雜志, 2017, 50(2): 91-98.
2. van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology, 2016, 87(14): 1449-1456.
3. 張婧, 趙文博, 武力勇. 富亮氨酸膠質瘤失活 1 蛋白 A 自身抗體相關邊緣性腦炎 6 例臨床分析. 中華實用診斷與治療雜志, 2015, 29(10): 995-996.
4. Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol, 2013, 265(1/2): 75-81.
5. Markovic I, Basic S, Devedjija S. Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab-a case report. Neurol Sci, 2020, 41(7): 1949-1950.
6. Brown JW, Martin PJ, Thorpe JW, et al. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. J Neuroimmunol, 2014, 271(1/2): 66-68.
7. Bhandari B, Basyal B, Sendil S, et al. Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis. J Community Hosp Intern Med Perspect, 2020, 10(4): 377-379.
8. Nosadini M, Mohammad SS, Ramanathan S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother, 2015, 15(12): 1391-1419.